公司資料
Nuvectis Pharma 股價、新聞與催化劑
- 股票代碼:
- NVCT
- 交易所:
- NYSE
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
23.56 USD (+0.90%)
收盤價
最後更新: 2026年8月21日
252M USD
市值
股價為何變動
As of Aug 21, 2026, NVCT closed up 0.90% at $23.56. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Nuvectis Pharma is an oncology company focused on targeted therapies for difficult cancers. Its development story is centered on precision oncology and smaller, data-sensitive programs.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Nuvectis sits in specialty oncology biotechnology.
商業模式特徵
The business depends on proof-of-concept, program prioritization, and the ability to build a differentiated oncology franchise.
生技產業定位
Nuvectis is a small-cap oncology catalyst name whose valuation can move sharply on early data.
未來催化劑
- Nuvectis’s catalysts are NXP900 and NXP800, the two oncology assets that define the story. The market will care about whether either program can show real differentiation.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。